AstraZeneca PLC · AZN · Next earnings

AstraZeneca PLC reports Tuesday, Feb 9, 2027

AZN reports before market open with consensus EPS at $2.41 and revenue at $16.66B. Last quarter: AstraZeneca pairs solid growth with pipeline investment and restructuring

Reports Before market open101 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $2.41 Calendar consensus
Consensus revenue $16.66B Calendar consensus
Report date Feb 9, 2027 Tuesday, date estimated
Session Before market open 101 days away

Where AZN left off: FY2026 Q3

Full report

AstraZeneca pairs solid growth with pipeline investment and restructuring

EPS surprise +7.3% Reported $2.79 vs $2.60
Revenue surprise +1.3% Reported $16.21B vs $16.00B
Stock move +7.0% Event window
Subsequent drift 0.0% Up to 20 sessions

Management maintained its guidance sentiment while pointing to continued growth despite loss-of-exclusivity headwinds.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Loss of exclusivity for Farxiga, Brilinta and other legacy products.
  • Pricing, procurement and rebate pressure, including in China.
  • Regulatory, launch and clinical execution risk across the pipeline.

Questions analysts left open

  • Whether the pipeline can distribute more than $20 billion of peak-year revenue potential across key readouts.
  • Pricing sustainability for Etcamah and adjuvant SERENA-6.
  • Execution of the $2 billion restructuring program and its effect on future margins.

Ask FN2 about AZN next report

Transcript, numbers and history already loaded
What should I watch for in AZN's next earnings report?How did AZN guide last quarter, and is consensus above or below that?Give me the bull and bear case going into AZN earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the AZN recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent AZN quarters

All AZN earnings
+7.0%FY2026 Q3

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.